Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study

BACKGROUND: Due to the progressive nature of type 2 diabetes mellitus (T2DM), antidiabetic treatment needs to be continuously intensified to avoid long-term complications. In T2DM patients on either basal insulin-supported oral therapy (BOT) or supplementary insulin therapy (SIT) presenting with HbA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vasc Health Risk Manag
Autors principals: Pfohl, Martin, Siegmund, Thorsten, Pscherer, Stefan, Pegelow, Katrin, Seufert, Jochen
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4642811/
https://ncbi.nlm.nih.gov/pubmed/26604774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S82720
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars